Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DB25FS6KL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $124,307
Award facts
- Contract value 100% obligated
- $124,306.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $124.3K by the Defense Logistics Agency on September 3, 2025, with completion targeted for September 24, 2025. The contract calls for the supply of Varivax vaccine with diluents under a firm fixed-price arrangement. This is a non-set-aside award, indicating the contract was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
The DLA Medical Supply Chain relies on AmerisourceBergen's extensive distribution capabilities to furnish vaccines, specialty medications, and medical supplies to support Defense Health Agency operations and other federal healthcare systems. This delivery order for Varivax, a varicella vaccine commonly used in military preventive health programs, reflects the ongoing demand for immunological products within the defense healthcare infrastructure. AmerisourceBergen's demonstrated capability to execute firm fixed-price delivery orders across a broad pharmaceutical portfolio positions the company as a critical vendor for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FS6KL?
SPE2DB25FS6KL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FS6KL worth?
The government has obligated $124,307 on SPE2DB25FS6KL.
Is contract SPE2DB25FS6KL an order under another contract?
Yes. SPE2DB25FS6KL is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6KL competed?
The extent of competition for SPE2DB25FS6KL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award